Stay updated on Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page.

Latest updates to the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.2 is now listed, replacing the previous Revision: v3.3.1. This appears to be a minor maintenance update with no user-facing changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check29 days agoChange DetectedRemoved a general government funding lapse notice from the page; this removal does not alter study details, eligibility criteria, or trial procedures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check43 days agoChange DetectedNo significant changes were detected; the Study Details page content and structure appear unchanged between screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedCore page content updated with a government operating-status notice and a version upgrade to v3.2.0; a specific resource reference (Carcinoma of esophagus) was removed.SummaryDifference2%

- Check79 days agoChange DetectedThe page now references revision v3.1.0 instead of v3.0.2, indicating an update to the version metadata. No other substantive content changes are indicated.SummaryDifference0.0%

Stay in the know with updates to Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page.